Company Update ALEMBIC PHARMACEUTICALS LTD. - 533573 - US FDA Inspection At Alembic Pharmaceuticals Limited'S Oncology (Injectable And … BSE India The USFDA has conducted an inspection at our Oncology (injectable and Oral Solid) Formulation Facility at Panelav from 28th February, 2024 to 8th March, 2024. The USFDA issued a Form 483 with four procedural observation.